Zoloft adds PMDD indication
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pfizer's Zoloft (sertraline) is approved for premenstrual dysphoric disorder May 16. Zoloft is the second selective serotonin reuptake inhibitor to gain the indicatio